Literature DB >> 8294221

Functional analysis of mononuclear cells infiltrating into tumors: establishment of T cell hybridomas exhibiting distinct interacting abilities with endothelial cells and extracellular matrix components.

E Uno1, K Kikuchi, I Saiki, T Uede.   

Abstract

We have established eleven T cell hybridoma cell lines to investigate mechanisms controlling interaction of T lymphocytes with endothelial cells as well as extracellular matrix (ECM) proteins at the clonal level. T cell hybridomas were characterized and subdivided into four groups on the basis of their interaction behavior with high endothelial venules (HEV). Group 1 (G1) exhibited strong adhesiveness. The binding was temperature- and divalent cation-dependent. Group 2 exhibited both adhesiveness and transendothelial migration (TEM, i.e., transmigration beneath the cytoplasm of endothelial cells). Group 3 exhibited strong TEM. G2 and G3 hybridomas exhibited temperature-independent and divalent cation-independent binding to HEV. Group 4 exhibited nonspecific adhesiveness to the surface of a slide glass. BW 5147, a parent of T cell hybridomas, was classified as G4. TEM was dependent on both the nature of T cell hybridomas and endothelial cells. TEM was completely temperature-dependent. TEM of G3 hybridomas was not divalent cation-dependent. Each group of T cell hybridomas interacted with various ECM components.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8294221      PMCID: PMC5919109          DOI: 10.1111/j.1349-7006.1993.tb02839.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  32 in total

Review 1.  Lymphocyte interactions with endothelial cells.

Authors:  Y Shimizu; W Newman; Y Tanaka; S Shaw
Journal:  Immunol Today       Date:  1992-03

2.  T cell receptor-dependent, antigen-specific stimulation of a murine T cell clone induces a transient, VLA protein-mediated binding to extracellular matrix.

Authors:  B M Chan; J G Wong; A Rao; M E Hemler
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

3.  Atherosclerosis and endothelium. Part 1. A simple method of endothelial cell culture from human atherosclerotic aorta.

Authors:  O Tokunaga; T Watanabe
Journal:  Acta Pathol Jpn       Date:  1987-04

4.  Rat T lymphocyte antigens comparable with mouse Lyt-1 and Lyt-2,3 antigenic systems: characterization by monoclonal antibodies.

Authors:  A Matsuura; Y Ishii; H Yuasa; H Narita; S Kon; T Takami; K Kikuchi
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

5.  Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell.

Authors:  N Oppenheimer-Marks; L S Davis; P E Lipsky
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

6.  Suppression of human lymphocyte chemotaxis and transendothelial migration by anti-LFA-1 antibody.

Authors:  D E Van Epps; J Potter; M Vachula; C W Smith; D C Anderson
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

7.  Functional analysis of mononuclear cells infiltrating into tumors. V. A. soluble factor involved in the regulation of cytotoxic/suppressor T cell infiltration into tumors.

Authors:  N Shijubo; T Uede; K Kikuchi
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

8.  Similarities in sequences and cellular expression between rat CD2 and CD4 antigens.

Authors:  A F Williams; A N Barclay; S J Clark; D J Paterson; A C Willis
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

9.  Inhibitory effect of fibronectin and its recombinant polypeptides on the adhesion of metastatic melanoma cells to laminin.

Authors:  I Saiki; T Makabe; J Yoneda; J Murata; Y Ishizaki; F Kimizuka; I Kato; I Azuma
Journal:  Jpn J Cancer Res       Date:  1991-10

10.  Inhibitory effect of antimetastatic fusion polypeptide of human fibronectin on tumor cell adhesion to extracellular matrices.

Authors:  Y Matsumoto; I Saiki; T Makabe; J Yoneda; J Murata; F Kimizuka; Y Ishizaki; I Kato; I Azuma
Journal:  Jpn J Cancer Res       Date:  1991-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.